Rhode Island Hospital receives $1.6M to study opioid treatment and care at pharmacies

RHODE ISLAND HOSPITAL has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care to people with opioid use disorder at pharmacies. / COURTESY LIFESPAN CORP.
RHODE ISLAND HOSPITAL has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care to people with opioid use disorder at pharmacies. / COURTESY LIFESPAN CORP.
PROVIDENCE – Rhode Island Hospital has received $1.6 million from the National Institutes of Health to study the effectiveness of providing medication and care at pharmacies for people with opioid-use disorder, Lifespan Corp. announced Monday The three-year study will be conducted in collaboration with the University of Rhode Island College of Pharmacy, the R.I. Department…

Register to keep reading or subscribe today and receive unlimited access.
Register Now Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

No posts to display